CLINICAL_TRIALS
trial_result
· 2011-02-23
Clinical Trial Update: Study of Erbitux (Cetuximab) in Patients With Metastatic Colorectal Carcinoma [Phase 2]
Summary
Phase 2 clinical trial update showing the study of cetuximab (Erbitux) in metastatic colorectal cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Colorectal Neoplasms, Metastases, Neoplasm | Phase 2 | Status: COMPLETED